Parvizi Josef 4
4 · Ceribell, Inc. · Filed Feb 19, 2026
Research Summary
AI-generated summary of this filing
Ceribell (CBLL) Director Josef Parvizi Sells Shares
What Happened
Josef Parvizi, a director of Ceribell, Inc. (CBLL), sold a total of 8,286 shares in two open‑market transactions on Feb 17–18, 2026. He disposed of 1,300 shares on Feb 17 for $20.00 each ($26,000) and 6,986 shares on Feb 18 at an average price of $20.00 ($139,720), for combined proceeds of about $165,720. These were sales (not purchases), and the filing indicates they were executed under a pre-arranged plan.
Key Details
- Transaction dates and prices: Feb 17, 2026 — 1,300 shares @ $20.00; Feb 18, 2026 — 6,986 shares @ weighted avg $20.00 (actual trades ranged $20.00–$20.02).
- Total shares sold: 8,286; estimated proceeds: ~$165,720.
- Shares owned after transaction: Not specified in the Form 4 filing.
- Notable footnotes: trades were made pursuant to a Rule 10b5‑1 trading plan adopted Aug 18, 2025 (F1); price is a weighted average with trades in the $20.00–$20.02 range and the filer will provide detail on request (F4). The filer is trustee/co‑trustee of several trusts and disclaims beneficial ownership except to his pecuniary interest (F2–F3, F5–F6).
- Filing timeliness: Form 4 was filed Feb 19, 2026, which is within the standard two‑business‑day reporting window for these transactions.
Context
Because the sales were executed under a 10b5‑1 plan (pre‑arranged trading program), they are typically routine scheduled disposals rather than ad‑hoc trades. Trust‑related footnotes indicate some shares may be held in trusts for which Parvizi is trustee or co‑trustee; such disclosures clarify potential beneficial ownership but do not change that these entries are sales.
Insider Transaction Report
- Sale
Common Stock
[F1][F2][F3]2026-02-17$20.00/sh−1,300$26,000→ 746,352 total(indirect: By Trust) - Sale
Common Stock
[F1][F4][F2][F3]2026-02-18$20.00/sh−6,986$139,720→ 739,366 total(indirect: By Trust)
- 907,911(indirect: By Trust)
Common Stock
[F3][F5] - 369,088(indirect: By Trust)
Common Stock
[F3][F6]
Footnotes (6)
- [F1]The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 18, 2025.
- [F2]The Reporting Person is the sole trustee of the Josef Parvizi Trust, and therefore may be deemed to have beneficial ownership of these securities.
- [F3]The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20 to $20.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote.
- [F5]The Reporting Person is a co-trustee of the Innovation ACP Trust, and therefore may be deemed to share beneficial ownership of these securities.
- [F6]The Reporting Person is a co-trustee of the ACP 2021 Trust, and therefore may be deemed to share beneficial ownership of these securities.